Skip to content
Disclosery

Tri Locum Partners LP

Follow

13F filer, CIK 1826434, NEW YORK, NY

Tri Locum Partners LP reported $712,549,412 across 17 holdings for the quarter ended 2026-03-31, in a 13F-HR filed 2026-05-18. Its ten largest share positions make up 81.58% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001826434-26-000004

Period
2026-03-31
Reported value
$713M
Holdings
17
Top 10 weight
81.58%
New
6
Sold out
4

Largest buys vs the previous quarter

SecurityShares changeApprox. value
ISRGnew+153,250$70.6M
TMOnew+132,413$65.1M
VRTXnew+129,314$57.7M
JAZZnew+158,663$30M
TARSnew+252,588$17.7M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
DHRexited-346,875-$79.4M
BSXexited-520,508-$49.6M
JNJreduced-188,640-$46.1M
IONSexited-557,174-$44.1M
VERAexited-805,689-$40.8M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q1 2026

Share positions as resolved from 13F-HR 0001826434-26-000004, largest first. % of portfolio is the value over $712,549,412, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
JNJJOHNSON & JOHNSONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 302,831 shares; 2025Q4: 603,143 shares; 2026Q1: 414,503 shares 414,503$101M14.22%-188,640Timeline
ISRGINTUITIVE SURGICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 12,824 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 153,250 shares 153,250$70.6M9.91%newTimeline
TMOTHERMO FISHER SCIENTIFIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 132,413 shares 132,413$65.1M9.13%newTimeline
ASNDASCENDIS PHARMA A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 32,325 shares; 2025Q2: 147,642 shares; 2025Q3: 174,829 shares; 2025Q4: 265,015 shares; 2026Q1: 255,332 shares 255,332$58.4M8.2%-9,683Timeline
VRTXVERTEX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 129,314 shares 129,314$57.7M8.1%newTimeline
LLYELI LILLY & COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 63,284 shares; 2026Q1: 61,795 shares 61,795$56.8M7.98%-1,489Timeline
MDGLMADRIGAL PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 43,287 shares; 2024Q4: 47,472 shares; 2025Q1: 37,869 shares; 2025Q2: 97,765 shares; 2025Q3: 67,706 shares; 2025Q4: 86,023 shares; 2026Q1: 103,288 shares 103,288$54.1M7.59%+17,265Timeline
DXCMDEXCOM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 421,600 shares; 2026Q1: 698,158 shares 698,158$43.8M6.15%+276,558Timeline
UTHRUNITED THERAPEUTICS CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 54,926 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 122,187 shares; 2025Q4: 120,921 shares; 2026Q1: 70,370 shares 70,370$41.7M5.86%-50,551Timeline
NUVLNUVALENT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 95,825 shares; 2025Q2: 75,973 shares; 2025Q3: not reported; 2025Q4: 307,371 shares; 2026Q1: 308,506 shares 308,506$31.6M4.44%+1,135Timeline
TEVATEVA PHARMACEUTICAL INDS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 2,755,737 shares; 2024Q4: 2,423,116 shares; 2025Q1: 1,061,008 shares; 2025Q2: 2,046,846 shares; 2025Q3: not reported; 2025Q4: 1,435,865 shares; 2026Q1: 1,021,008 shares 1,021,008$30.8M4.32%-414,857Timeline
JAZZJAZZ PHARMACEUTICALS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 161,812 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 158,663 shares 158,663$30M4.21%newTimeline
ARGXARGENX SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 62,474 shares; 2024Q4: 58,258 shares; 2025Q1: 17,844 shares; 2025Q2: 47,793 shares; 2025Q3: 43,411 shares; 2025Q4: 37,653 shares; 2026Q1: 31,635 shares 31,635$23.1M3.24%-6,018Timeline
TARSTARSUS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 177,656 shares; 2025Q3: 119,260 shares; 2025Q4: not reported; 2026Q1: 252,588 shares 252,588$17.7M2.49%newTimeline
DNTHDIANTHUS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 182,867 shares; 2025Q4: 622,403 shares; 2026Q1: 145,543 shares 145,543$12.2M1.71%-476,860Timeline
AXSMAXSOME THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 91,721 shares; 2024Q4: 249,769 shares; 2025Q1: 101,240 shares; 2025Q2: 157,861 shares; 2025Q3: 292,137 shares; 2025Q4: 201,627 shares; 2026Q1: 62,116 shares 62,116$10.5M1.47%-139,511Timeline
DFTXDEFINIUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 369,588 shares 369,588$6.99M0.98%newTimeline

Sold out in Q1 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
DHRDANAHER CORP DEL346,875$79.4Mshares
BSXBOSTON SCIENTIFIC CORP520,508$49.6Mshares
IONSIONIS PHARMACEUTICALS INC557,174$44.1Mshares
VERAVERA THERAPEUTICS INC805,689$40.8Mshares

How Q1 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001826434-26-000004 base2026-05-18acceptance time not in the bulk data set